Daly City, CA, United States of America

Anthony R Gangloff


Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 58(Granted Patents)


Location History:

  • San Mateo, CA (US) (2000 - 2001)
  • Pacifica, CA (US) (2002 - 2003)
  • Daly City, CA (US) (2003 - 2007)

Company Filing History:


Years Active: 2000-2007

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Anthony R. Gangloff: A Pioneer in Estrogen Modulation

Introduction

Anthony R. Gangloff is an accomplished inventor based in Daly City, California, with a remarkable portfolio of six patents. His innovative work primarily focuses on the modulation of estrogen receptors, which has significant implications for treating various estrogen-related medical conditions. His contributions are not only groundbreaking but also pivotal in advancing pharmaceutical compositions that can improve patient outcomes.

Latest Patents

Anthony has pioneered methods and compounds that modulate estrogen receptors, particularly targeting the estrogen receptor beta (ER-β) over the estrogen receptor alpha (ER-α). His latest patents detail pharmaceutical compositions that utilize these compounds for effective modulation in cellular and tissue settings. This innovation is especially crucial for addressing numerous estrogen-related conditions such as breast cancer, osteoporosis, cardiovascular diseases, and various hormonal imbalances. The potential applications of his discoveries extend to treating symptoms like hot flashes, mood swings, and even skin effects related to hormonal changes.

Career Highlights

Throughout his career, Anthony R. Gangloff has made significant strides in pharmaceutical research and development. He has worked with notable companies including Signal Pharmaceuticals and Axys Pharmaceuticals. His time in these organizations has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his innovations and contributions to the field.

Collaborations

Anthony was fortunate to collaborate with respected colleagues such as Kenneth D. Rice and Shripad S. Bhagwat. Their collective expertise and insights have undoubtedly amplified the impact of their research initiatives, leading to substantial advancements in the understanding of estrogen modulation.

Conclusion

Anthony R. Gangloff stands out as a prominent figure in the realm of estrogen receptor modulation, with his patents reflecting a commitment to addressing pressing health concerns. His work not only showcases his ingenuity but also paves the way for future innovations in the treatment of estrogen-related conditions. As his research continues to evolve, the contributions of Anthony R. Gangloff remain vital to both the scientific community and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…